Hemostatic and antifibrinolytic agent
PCP: Signs of shock or hypoperfusion in association with an injury suggestive of occult or ongoing bleeding
PCP: Signs of shock or hypoperfusion in association with an injury suggestive of occult or ongoing bleeding
ACP: Signs of shock or hypoperfusion in association with an injury suggestive of occult or ongoing bleeding
Prevents clot degradation by competing for TPA receptor sites
Intravenous:
May potentiate hypotension if administered too quickly
For intravenous infusion use only. Do not administer as a push dose, or intramuscularly or subcutaneously.